How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

For Vijay, the endeavour was never about questioning whether the Mahabharata should be retold. As creative industries across the world grapple with how best to harness artificial intelligence in ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Bryan Metzger Every time Bryan publishes a story, you’ll get an alert straight to your inbox!

Micah Castelo is a web editor for EdTech: Focus on K-12. Her experience includes education and community news coverage for the Syracuse Post-Standard and international news reporting for the Pulitzer ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Lita Epstein has 18+ years of experience as an author and financial writer. She has also written over 40 books. Yarilet Perez is an experienced multimedia journalist and fact-checker with a Master of ...

Google's Nano Banana Pro earned a near-perfect score. ChatGPT image ranked second; others often mangled text and faces. Nine tough prompts reveal which AIs are worth subscribing to. When generative AI ...

Allie is a financial writer and editor with over five years of experience. An investment banker turned journalist, she has previously reported on cryptocurrency for MT Newswires and edited ...